bullish
Hanmi Pharmaceutical: This Korean Pharma Giant's Stock Could Rebound More than 50%.
621 Views27 Oct 2016 13:48
Hanmi Pharm Co Ltd (128940 KS) stock has fallen from recent highs after Boehringer pulled out of an oncology deal and short-sellers piled on the...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Korea Biotech & Healthcare: A Pair Trade Between Hanmi Science and Hanmi Pharm21 Dec 2022
- Hanmi Science Merger: Proxy Battle-Triggered Momentum Trading29 Aug 2022
- A Long-Term M&A Battle Brewing Among the 3 Heirs of Hanmi Pharm Group?16 Mar 2022
- Hanmi Pharmaceutical: This Korean Pharma Giant's Stock Could Rebound More than 50%.27 Oct 2016
x